Patents Assigned to Biocytogen Boston Corp
  • DNA knock-in system
    Patent number: 11071289
    Abstract: The present disclosure relates to an efficient genome editing technique. In one aspect, the technique can greatly improve the efficiency of homologous recombination during intracellular targeting, including gene targeting. Using this technique, genetically modified cell lines, rat, mouse, zebrafish, and fertilized eggs of other species can be quickly and efficiently generated.
    Type: Grant
    Filed: August 13, 2015
    Date of Patent: July 27, 2021
    Assignee: Biocytogen Boston Corp
    Inventor: Yuelei Shen
  • DNA knock-in system
    Patent number: 10314297
    Abstract: The present disclosure relates to an efficient genome editing technique. In one aspect, the technique can greatly improve the efficiency of homologous recombination during intracellular targeting, including gene targeting. Using this technique, genetically modified cell lines, rat, mouse, zebrafish, and fertilized eggs of other species can be quickly and efficiently generated.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: June 11, 2019
    Assignee: Biocytogen Boston Corp
    Inventor: Yuelei Shen